PR Newswire
NEW YORK
,
March 15, 2022
/PRNewswire/ —
WHY:
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL) resulting from allegations that Anavex may have issued materially misleading business information to the investing public.
SO WHAT:
If you purchased Anavex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT:
To join the prospective class action, go to
or call
Phillip Kim, Esq.
toll-free at 866-767-3653 or email
[email protected]
or
[email protected]
for information on the class action.
WHAT IS THIS ABOUT:
On
February 1, 2022
, before the market opened, Anavex announced that a phase 3 trial of ANAVEX2-73 (blarcamesine) for Rett syndrome met primary and secondary endpoints. Following the announcement, several people on social media indicated that the primary and secondary endpoints were recently changed. STAT’s
Adam Feuerstein
tweeted, “Anavex changed the primary and secondary endpoints of this Rett study on
Jan. 18
, allowing it to claim success when the drug most likely failed.”
On this news, Anavex stock fell
$2.04
per share, or 15%, to close at
$11.04
per share on
February 1, 2022
, damaging investors.
WHY ROSEN LAW:
We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over
$438 million
for investors. In 2020, founding partner
Laurence Rosen
was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm
, on Twitter:
Tweets by rosen_firm
or on Facebook:
https://www.facebook.com/rosenlawfirm/
.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY
10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
View original content to download multimedia:
https://www.prnewswire.com/news-releases/rosen-a-leading-law-firm-encourages-anavex-life-sciences-corp-investors-to-inquire-about-securities-class-action-investigation–avxl-301503644.html
SOURCE Rosen Law Firm, P.A.
